Management in Intensive Care Unit of Life-threatening Keto-Acidosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

70 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-02-02

Study Completion Date

2024-06-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients hospitalized in intensive care between January 2014 and December 2023 for ketoacidosis complicated by organ failure in participating departments.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

French and EuRopean Outcome Registry in Intensive Care Unit

NCT01367093

Intensive Care Unit Syndrome Tracheal Intubation Morbidity

COMPLETED

Functional ICUS in Uganda and Their Survival Outcomes

NCT03511742

Critical Illness

UNKNOWN

Sepsis in ICU:Causes and Outcomes of Sepsis in Diabetics Versus Non Diabetics in Assiut University Hospital

NCT04015752

Septic Shock Sepsis

UNKNOWN

International Registry on the Use of the CytoSorb Adsorber

NCT02312024

Sepsis Need of Cardiac Surgery

COMPLETED

Serum CD14 and CD88 Mointoring in ICU

NCT02120534

Sepsis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Analysis of patients with International Statistical Classification of Diseases and Related Health Problems coding compatible with inclusion

* Selection of patients eligible for inclusion based on review of medical records (verification of inclusion and non-inclusion criteria)
* Telephone contact and sending of the information letter on participation in the study and research of the patient's non-opposition to his participation and the processing of his data.
* Collection of retrospective data
* Phone call to collect prospective data

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ketoacidosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Major (age ≥ 18 years old)
* Hospitalized in intensive care between January 2014 and December 2023 for ketoacidosis complicated by organ failure in the participating departments.
* Diagnosis of ketoacidosis judged to be the main cause of the severity of the clinical condition.
* Blood potential hydrogen \< 7.15 and bicarbonates \< 10mmol/L in the first 12 hours of treatment.
* Presenting at least one of the 3 organ failures during hospitalization among:
* Use of extra-renal purification for acute renal failure
* Administration of pressor amines
* Use of mechanical ventilation

Exclusion Criteria

* Metabolic acidosis primarily of an origin other than ketonic
* Refusal to participate or opposition to the processing of their data
* Patient under guardianship or curators

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No